Effect of simultaneous AZT and hydroxyurea (HU): study in an HL-60 model system. (Research Report)

N.J. Nusbaum and P Joseph. Lee Streich Flow Cytometry Laboratory, Hematology/Oncology Division, Brookdale Hospital Medi Brooklyn, New York.

According to an abstract submitted to the Twenty-Ninth Annual Meeting of the American Society of Clinical Oncology, held May 16-18, 1993, in Orlando, Florida, "Patients with AIDS-related neoplasms may be considered for treatment with AZT, other antiretroviral agents, therapy for opportunistic infections, and/or cancer chemotherapy. These multiple medications are often poorly tolerated in this patient population, and so there is often interest in trying gentler chemotherapy than one might use in a similar cancer patient without HIV …